vs
Acadia Healthcare Company, Inc.（ACHC）与WEX Inc.（WEX）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是WEX Inc.的1.2倍（$821.5M vs $673.8M），WEX Inc.净利率更高（11.5% vs -143.3%，领先154.9%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs 5.8%），WEX Inc.自由现金流更多（$49.5M vs $-179.5M），过去两年WEX Inc.的营收复合增速更高（18.7% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
WEX Inc.是专注服务于美国商业及政府车队领域的支付处理与信息管理服务提供商，总部位于美国缅因州波特兰市，业务范围覆盖美国、加拿大、南美、欧洲、亚洲及澳大利亚等多个全球区域。
ACHC vs WEX — 直观对比
营收规模更大
ACHC
是对方的1.2倍
$673.8M
营收增速更快
ACHC
高出0.3%
5.8%
净利率更高
WEX
高出154.9%
-143.3%
自由现金流更多
WEX
多$229.0M
$-179.5M
两年增速更快
WEX
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $673.8M |
| 净利润 | $-1.2B | $77.7M |
| 毛利率 | — | — |
| 营业利润率 | -142.4% | 23.5% |
| 净利率 | -143.3% | 11.5% |
| 营收同比 | 6.1% | 5.8% |
| 净利润同比 | -3710.4% | 8.7% |
| 每股收益（稀释后） | $-12.98 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCWEX
| Q1 26 | — | $673.8M | ||
| Q4 25 | $821.5M | $465.1M | ||
| Q3 25 | $851.6M | $481.6M | ||
| Q2 25 | $869.2M | $454.4M | ||
| Q1 25 | $770.5M | $444.3M | ||
| Q4 24 | $774.2M | $440.3M | ||
| Q3 24 | $815.6M | $479.0M | ||
| Q2 24 | $796.0M | $478.6M |
净利润ACHCWEX
| Q1 26 | — | $77.7M | ||
| Q4 25 | $-1.2B | $84.2M | ||
| Q3 25 | $36.2M | $80.3M | ||
| Q2 25 | $30.1M | $68.1M | ||
| Q1 25 | $8.4M | $71.5M | ||
| Q4 24 | $32.6M | $63.9M | ||
| Q3 24 | $68.1M | $102.9M | ||
| Q2 24 | $78.5M | $77.0M |
毛利率ACHCWEX
| Q1 26 | — | — | ||
| Q4 25 | — | 39.0% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | — | 40.0% | ||
| Q1 25 | — | 39.2% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 48.0% | ||
| Q2 24 | — | 44.9% |
营业利润率ACHCWEX
| Q1 26 | — | 23.5% | ||
| Q4 25 | -142.4% | 35.7% | ||
| Q3 25 | 4.7% | 38.1% | ||
| Q2 25 | 5.8% | 34.5% | ||
| Q1 25 | 1.7% | 35.4% | ||
| Q4 24 | 4.9% | 35.7% | ||
| Q3 24 | 12.1% | 41.0% | ||
| Q2 24 | 13.4% | 35.1% |
净利率ACHCWEX
| Q1 26 | — | 11.5% | ||
| Q4 25 | -143.3% | 18.1% | ||
| Q3 25 | 4.3% | 16.7% | ||
| Q2 25 | 3.5% | 15.0% | ||
| Q1 25 | 1.1% | 16.1% | ||
| Q4 24 | 4.2% | 14.5% | ||
| Q3 24 | 8.4% | 21.5% | ||
| Q2 24 | 9.9% | 16.1% |
每股收益（稀释后）ACHCWEX
| Q1 26 | — | $2.22 | ||
| Q4 25 | $-12.98 | $2.38 | ||
| Q3 25 | $0.40 | $2.30 | ||
| Q2 25 | $0.33 | $1.98 | ||
| Q1 25 | $0.09 | $1.81 | ||
| Q4 24 | $0.36 | $1.60 | ||
| Q3 24 | $0.74 | $2.52 | ||
| Q2 24 | $0.85 | $1.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $633.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $1.3B |
| 总资产 | $5.5B | $15.4B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCWEX
| Q1 26 | — | $633.5M | ||
| Q4 25 | $133.2M | $5.2B | ||
| Q3 25 | $118.7M | $4.9B | ||
| Q2 25 | $131.4M | $4.9B | ||
| Q1 25 | $91.2M | $4.4B | ||
| Q4 24 | $76.3M | $4.4B | ||
| Q3 24 | $82.1M | $4.3B | ||
| Q2 24 | $77.2M | $4.0B |
总债务ACHCWEX
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCWEX
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $3.1B | $1.1B | ||
| Q2 25 | $3.1B | $978.7M | ||
| Q1 25 | $3.0B | $810.4M | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.7B | ||
| Q2 24 | $3.0B | $1.8B |
总资产ACHCWEX
| Q1 26 | — | $15.4B | ||
| Q4 25 | $5.5B | $14.4B | ||
| Q3 25 | $6.4B | $14.4B | ||
| Q2 25 | $6.3B | $14.7B | ||
| Q1 25 | $6.1B | $14.0B | ||
| Q4 24 | $6.0B | $13.3B | ||
| Q3 24 | $5.9B | $14.0B | ||
| Q2 24 | $5.7B | $14.2B |
负债/权益比ACHCWEX
| Q1 26 | — | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $49.5M |
| 自由现金流率自由现金流/营收 | -21.8% | 7.3% |
| 资本支出强度资本支出/营收 | 11.3% | 5.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $877.4M |
8季度趋势，按日历期对齐
经营现金流ACHCWEX
| Q1 26 | — | — | ||
| Q4 25 | $-86.3M | $294.7M | ||
| Q3 25 | $73.2M | $376.6M | ||
| Q2 25 | $133.5M | $264.6M | ||
| Q1 25 | $11.5M | $-481.6M | ||
| Q4 24 | $116.7M | $638.4M | ||
| Q3 24 | $163.1M | $3.3M | ||
| Q2 24 | $171.1M | $-7.0M |
自由现金流ACHCWEX
| Q1 26 | — | $49.5M | ||
| Q4 25 | $-179.5M | $256.3M | ||
| Q3 25 | $-63.0M | $341.6M | ||
| Q2 25 | $-34.2M | $230.0M | ||
| Q1 25 | $-163.2M | $-514.2M | ||
| Q4 24 | $-86.8M | $599.7M | ||
| Q3 24 | $-27.1M | $-31.7M | ||
| Q2 24 | $16.9M | $-46.6M |
自由现金流率ACHCWEX
| Q1 26 | — | 7.3% | ||
| Q4 25 | -21.8% | 55.1% | ||
| Q3 25 | -7.4% | 70.9% | ||
| Q2 25 | -3.9% | 50.6% | ||
| Q1 25 | -21.2% | -115.7% | ||
| Q4 24 | -11.2% | 136.2% | ||
| Q3 24 | -3.3% | -6.6% | ||
| Q2 24 | 2.1% | -9.7% |
资本支出强度ACHCWEX
| Q1 26 | — | 5.6% | ||
| Q4 25 | 11.3% | 8.3% | ||
| Q3 25 | 16.0% | 7.3% | ||
| Q2 25 | 19.3% | 7.6% | ||
| Q1 25 | 22.7% | 7.3% | ||
| Q4 24 | 26.3% | 8.8% | ||
| Q3 24 | 23.3% | 7.3% | ||
| Q2 24 | 19.4% | 8.3% |
现金转化率ACHCWEX
| Q1 26 | — | — | ||
| Q4 25 | — | 3.50× | ||
| Q3 25 | 2.02× | 4.69× | ||
| Q2 25 | 4.43× | 3.89× | ||
| Q1 25 | 1.37× | -6.74× | ||
| Q4 24 | 3.58× | 9.99× | ||
| Q3 24 | 2.39× | 0.03× | ||
| Q2 24 | 2.18× | -0.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
WEX
| Payment processing revenue | $284.2M | 42% |
| Account servicing revenue | $182.5M | 27% |
| Other revenue | $127.0M | 19% |
| Finance fee revenue | $80.1M | 12% |
